BMC Cancer 2005, 5:3 http://www.biomedcentral.com/1471-2407/5/3 cytosolic 120-kd protein in a cloned mouse mammary epi- thelial cell line. Embo J 1988, 7:2089-2095. 24. Kenny PA, Enver T, Ashworth A: Retroviral vectors for establish- ing tetracycline-regulated gene expression in an otherwise recalcitrant cell line. BMC Molecular Biology 2002, 3:13. 25. Pear WS, Nolan GP, Scott ML, Baltimore D: Production of high- titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 1993, 90:8392-8396. 26. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 1990, 215:403-410. 27. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685. 28. Sawano A, Miyawaki A: Directed evolution of green fluorescent protein by a new versatile PCR strategy for site-directed and semi-random mutagenesis. Nucleic Acids Res 2000, 28:E78. 29. Gradl D, Kuhl M, Wedlich D: The Wnt/Wg signal transducer beta-catenin controls fibronectin expression. Mol Cell Biol 1999, 19:5576-5587. 30. Tice DA, Szeto W, Soloviev I, Rubinfeld B, Fong SE, Dugger DL, Winer J, Williams PM, Wieand D, Smith V, Schwall RH, Pennnica D, Polakis P: Synergistic activation of tumor antigens by wnt-1 signaling and retinoic acid revealed by gene expression profiling. J Biol Chem 2002, 6:6. 31. Denko N, Schindler C, Koong A, Laderoute K, Green C, Giaccia A: Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. Clin Cancer Res 2000, 6:480-487. 32. SignalP 3.0 [http://www.cbs.dtu.dk/services/SignalP/] 33. Nielsen H, Engelbrecht J, Brunak S, von Heijne G: Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 1997, 10:1-6. 34. Tanudji M, Hevi S, Chuck SL: Improperly folded green fluores- cent protein is secreted via a non-classical pathway. J Cell Sci 2002, 115:3849-3857. 35. Jain RK, Joyce PB, Molinete M, Halban PA, Gorr SU: Oligomeriza- tion of green fluorescent protein in the secretory pathway of endocrine cells. Biochem J 2001, 360:645-649. 36. Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiff- mann E, Liotta LA: Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 1992, 267:2524-2529. 37. Murata J, Lee HY, Clair T, Krutzsch HC, Arestad AA, Sobel ME, Liotta LA, Stracke ML: cDNA cloning of the human tumor motility- stimulating protein, autotaxin, reveals a homology with phosphodiesterases. J Biol Chem 1994, 269:30479-30484. 38. Nam SW, Clair T, Campo CK, Lee HY, Liotta LA, Stracke ML: Auto- taxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Oncogene 2000, 19:241-247. 39. Nam SW, Clair T, Kim YS, McMarlin A, Schiffmann E, Liotta LA, Stracke ML: Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res 2001, 61:6938-6944. 40. Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, Fukuzawa K: Identification of human plasma lysophospholi- pase D, a lysophosphatidic acid-producing enzyme, as auto- taxin, a multifunctional phosphodiesterase. J Biol Chem 2002, 277:39436-39442. 41. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J, Arai H: Autotaxin has lyso- phospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 2002, 158:227-233. 42. Mathieu E, Meheus L, Raymackers J, Merregaert J: Characterization of the osteogenic stromal cell line MN7: identification of secreted MN7 proteins using two-dimensional polyacryla- mide gel electrophoresis, western blotting, and microsequencing. J Bone Miner Res 1994, 9:903-913. 43. Wang L, Yu J, Ni J, Xu XM, Wang J, Ning H, Pei XF, Chen J, Yang S, Underhill CB, Liu L, Liekens J, Merregaert J, Zhang L: Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epi- thelial tumors. Cancer Lett 2003, 200:57-67. 44. Hamada T, McLean WH, Ramsay M, Ashton GH, Nanda A, Jenkins T, Edelstein I, South AP, Bleck O, Wessagowit V, Mallipeddi R, Orchard GE, Wan H, Dopping-Hepenstal PJ, Mellerio JE, Whittock NV, Munro CS, van Steensel MA, Steijlen PM, Ni J, Zhang L, Hashimoto T, Eady RA, McGrath JA: Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet 2002, 11:833-840. 45. Zhang X, Gaspard JP, Chung DC: Regulation of vascular endothe- lial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res 2001, 61:6050-6054. 46. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433. 47. Labeta MO, Vidal K, Nores JE, Arias M, Vita N, Morgan BP, Guillemot JC, Loyaux D, Ferrara P, Schmid D, Affolter M, Borysiewicz LK, Don- net-Hughes A, Schiffrin EJ: Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14. J Exp Med 2000, 191:1807-1812. 48. Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, Heath VJ, Bell AK, Ferrier RK, Sandilands GP, Gusterson BA: Involution of the mouse mammary gland is associated with an immune cas- cade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 2004, 6:R75-R91. 49. Sexton PM, Albiston A, Morfis M, Tilakaratne N: Receptor activity modifying proteins. Cell Signal 2001, 13:73-83. 50. Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ, Main MJ, Foord SM, Sexton PM: Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 1999, 56:235-242. 51. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM: RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998, 393:333-339. 52. Miller MJ, Martinez A, Unsworth EJ, Thiele CJ, Moody TW, Elsasser T, Cuttitta F: Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J Biol Chem 1996, 271:23345-23351. 53. Oehler MK, Hague S, Rees MC, Bicknell R: Adrenomedullin pro- motes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis. Oncogene 2002, 21:2815-2821. 54. Fernandez-Sauze S, Delfino C, Mabrouk K, Dussert C, Chinot O, Martin PM, Grisoli F, Ouafik L, Boudouresque F: Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/ RAMP3 receptors. Int J Cancer 2004, 108:797-804. 55. Ouafik L, Sauze S, Boudouresque F, Chinot O, Delfino C, Fina F, Vua- roqueaux V, Dussert C, Palmari J, Dufour H, Grisoli F, Casellas P, Brunner N, Martin PM: Neutralization of adrenomedullin inhib- its the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am J Pathol 2002, 160:1279-1292. 56. Shennan DB, Peaker M: Transport of milk constituents by the mammary gland. Physiol Rev 2000, 80:925-951. 57. Mitelman Database of Chromosome Aberrations in Cancer [http://cgap.nci.nih.gov/Chromosomes/Mitelman] 58. Gruszka-Westwood AM, Hamoudi R, Osborne L, Matutes E, Catovsky D: Deletion mapping on the long arm of chromo- some 7 in splenic lymphoma with villous lymphocytes. Genes Chromosomes Cancer 2003, 36:57-69. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/5/3/prepub Page 9 of 9 (page number not for citation purposes)